Adler Footcare of Greater New York Offers New Treatment for Damaged Soft Tissue in the Feet

Adler Footcare of Greater New York is now offering a service called AmnioGenic Therapy™ used to treat damaged soft tissue in the feet that helps advance the healing process. The use of amniotic fluid has been FDA approved since 2005 and used by physicians for over a century.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
The therapy promotes a healthy environment for cells to grow and replace damaged areas in the feet.

New York, NY (PRWEB) April 19, 2013

Adler Footcare of Greater New York is offering a new treatment called AmnioGenic Therapy™ that injects a mixture of amniotic tissue and fluid to treat damaged areas in the feet and ankles caused by a soft tissue defect, tear or injury. The treatment has been used for over a hundred years and is FDA approved.

The amniotic tissue and fluid is a simple injection used for its growth benefits. It is a rich source of nutrients made up of proteins, carbohydrates, lipids, and hyaluronic acid that already exist within the human body. The therapy promotes a healthy environment for the cells to attach on to and grow in to replace the damaged areas in the feet.

AmnioGenic Therapy™ is used to treat multiple issues related to podiatry, including but not limited to Plantar Faciitis, Achilles Tendonitis, Cheilectomy, which is the removal of bone spurs at the base of the big toe during minimally invasive bunion correction surgery, and Tarsal Tunnel Syndrome. Treatment usually consists of one or two applications and there are no known side effects. It also produces a non-arthritic big toe joint months earlier that with just surgery alone. Recovery time depends on each individual patient’s medical diagnosis and overall general health.

Treatments using amniotic membrane and fluid have been used by physicians for over 100 years. AmnioGenic Therapy™ is covered by commercial insurance and Medicare, and is approved and regulated by the FDA. The product is tested and screened by medical professionals to eliminate the potential of any communicable diseases.

To learn more about AmnioGenic Therapy™ or to schedule a consultation with a podiatrist at Adler Footcare, call (646) 783-1618 or visit http://www.mynycpodiatrist.com.

About Adler Footcare of Greater New York
Dr. Jeffrey L. Adler, Medical/Surgical Director and owner of Adler Footcare of Greater New York has been practicing podiatric medicine since 1979 and has performed thousands of foot and ankle surgeries. Dr. Adler is board certified in Podiatric Surgery and Primary Podiatric Medicine by the American Board of Multiple Specialties in Podiatry. Dr. Adler is also a Professor of Minimally Invasive Foot Surgery for the Academy of Ambulatory Foot and Ankle Surgeons. As one of only several in the country who perform minimally invasive podiatric surgery, Dr. Adler’s patients enjoy significantly reduced recovery times. Learn more about Adler Footcare of Greater New York at http://www.mynycpodiatrist.com.


Contact